Stroke prevention in nonvalvular atrial fibrillation

Tex Heart Inst J. 2011;38(4):350-2.

Authors

Leila Ganjehei¹, Ali Massumi, Mehdi Razavi, Abdi Rasekh

Affiliation

¹ Department of Cardiology, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA.

PMID: 21841857
PMCID: PMC3147190

No abstract available

Publication types

Review

MeSH terms

Anticoagulants / adverse effects
Anticoagulants / therapeutic use*
Atrial Appendage / surgery
Atrial Fibrillation / complications
Atrial Fibrillation / drug therapy
Atrial Fibrillation / surgery
Atrial Fibrillation / therapy*
Benzimidazoles / therapeutic use
Cardiac Catheterization* / adverse effects
Cardiac Catheterization* / instrumentation
Cardiac Surgical Procedures* / adverse effects
Cardiac Surgical Procedures* / instrumentation
Dabigatran
Humans
Preventive Health Services*
Stroke / etiology
Stroke / prevention & control*
Treatment Outcome
Warfarin / therapeutic use
beta-Alanine / analogs & derivatives
beta-Alanine / therapeutic use

Substances

Anticoagulants
Benzimidazoles
beta-Alanine
Warfarin
Dabigatran